Venkateswara Rao Thallapaka
About Venkateswara Rao Thallapaka
Data last updated:
Venkateswara Rao Thallapaka is a Director at Indian Immunologicals Limited (since 2025), Director at Lendingkart Finance Limited (since 2019) and Director at Stci Primary Dealer Limited (since 2019), and holds 7 more current directorships. The companies operate in Pharma, Financial Services and Healthcare. The 10 current companies with reported revenue have a combined latest revenue of ₹3,677 Cr; the largest is Indian Immunologicals Limited at ₹1,513 Cr (FY 2025). Earlier, Venkateswara Rao Thallapaka was a Director at Natco Pharma Limited (2012–2024) and Director at Ladderup Finance Limited (2016–2024) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indian Immunologicals Limited U72200TG1999PLC032666 | Director | 18 Mar 2025 | 1999 | ₹1,513 Cr (FY 2025) | Active |
 Lendingkart Finance Limited U65910MH1996PLC258722 | Director | 13 Nov 2019 | 1996 | ₹867 Cr (FY 2025) | Active |
 Stci Primary Dealer Limited U67110MH2006PLC165306 | Director | 23 Jan 2019 | 2006 | ₹671 Cr (FY 2019) | Active |
 Cupid Limited L25193MH1993PLC070846 | Director | 20 Oct 2023 | 1993 | ₹391 Cr (FY 2026) | Active |
 Easy Home Finance Limited U74999MH2017PLC297819 | Director | 07 Aug 2017 | 2017 | ₹105 Cr (FY 2025) | Active |
| Lendingkart Technologies Private Limited U72900GJ2014PTC081539 | Director | 27 Mar 2025 | 2014 | ₹49.52 Cr (FY 2025) | Active |
 Bgse Financials Limited U67120KA1999PLC025860 | Director | 04 Nov 2024 | 1999 | ₹31.53 Cr (FY 2025) | Active |
 Alkali Metals Ltd L27109TG1968PLC001196 | Director | 21 Aug 2024 | 1968 | ₹23.74 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Natco Pharma Limited L24230TG1981PLC003201 | Director | 18 Apr 2012 | 1981 | ₹4,784 Cr (FY 2025) | Active |
 Ladderup Finance Limited L67120MH1993PLC074278 | Director | 11 Aug 2016 | 1993 | ₹12.62 Cr (FY 2024) | Active |
 Pnb Metlife India Insurance Company Limited U66010KA2001PLC028883 | Nominee Director | 19 Mar 2020 | 2001 | ₹385 Cr (FY 2024) | Active |
 Canara Bank Securities Limited U67120MH1996GOI097783 | Director | 12 May 2020 | 1996 | ₹52.03 Cr (FY 2025) | Active |
 Kisan Mouldings Limited L17120MH1989PLC054305 | Director | 14 Feb 2015 | 1989 | ₹274 Cr (FY 2025) | Active |
 Can Fin Homes Limited L85110KA1987PLC008699 | Director | 01 Feb 2014 | 1987 | ₹4,218 Cr (FY 2026) | Active |
 Lic Housing Finance Ltd L65922MH1989PLC052257 | Director | 01 Aug 2013 | 1989 | ₹28,843 Cr (FY 2026) | Active |
 Electronica Finance Limited U74110PN1990PLC057017 | Director | 11 Jun 2013 | 1990 | ₹587 Cr (FY 2025) | Active |
 Munz Fintech Private Limited U65990TG2021PTC149761 | Director | 18 Mar 2021 | 2021 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Venkateswara Rao Thallapaka
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Venkateswara Rao Thallapaka
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Venkateswara Rao Thallapaka
Venkateswara Rao Thallapaka currently holds 10 directorships: Indian Immunologicals Limited (Director, since 18 Mar 2025, revenue ₹1,513 Cr (FY 2025)); Lendingkart Finance Limited (Director, since 13 Nov 2019, revenue ₹867 Cr (FY 2025)); Stci Primary Dealer Limited (Director, since 23 Jan 2019, revenue ₹671 Cr (FY 2019)); Cupid Limited (Director, since 20 Oct 2023, revenue ₹391 Cr (FY 2026)); Easy Home Finance Limited (Director, since 07 Aug 2017, revenue ₹105 Cr (FY 2025)); and 5 more.
Venkateswara Rao Thallapaka was first appointed on 18 Apr 2012 as Director at Natco Pharma Limited. The most recent appointment on record is 27 Mar 2025 at Lendingkart Technologies Private Limited.
The 10 current companies of Venkateswara Rao Thallapaka that report revenue have a combined latest revenue of ₹3,677 Cr: Indian Immunologicals Limited ₹1,513 Cr (FY 2025); Lendingkart Finance Limited ₹867 Cr (FY 2025); Stci Primary Dealer Limited ₹671 Cr (FY 2019); Cupid Limited ₹391 Cr (FY 2026); Easy Home Finance Limited ₹105 Cr (FY 2025); and 5 more.
Venkateswara Rao Thallapaka held 13 earlier board appointments: Natco Pharma Limited (Director, 18 Apr 2012 to 24 Aug 2024); Ladderup Finance Limited (Director, 11 Aug 2016 to 10 Aug 2024); Pnb Metlife India Insurance Company Limited (Nominee Director, 19 Mar 2020 to 15 Dec 2023); Canara Bank Securities Limited (Director, 12 May 2020 to 03 Jan 2023); Kisan Mouldings Limited (Director, 14 Feb 2015 to 01 Jul 2017); and 8 more.
The current boards of Venkateswara Rao Thallapaka's companies include Anand Kumar Kanakasapapathy (Indian Immunologicals Limited), Appalaraja Sekhar Ganasala (Indian Immunologicals Limited), Devanand Chakkingal Pathayapura (Indian Immunologicals Limited), Meeneshkumar Champaklal Shah (Indian Immunologicals Limited), Rajeev Sivarama (Indian Immunologicals Limited), Sanjay Madhav Mehendale (Indian Immunologicals Limited), among others.